Compare Novavax Inc (NVAX) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Standard Lithium Ltd — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Standard Lithium Ltd trades at $2.27 (market cap $523.89M). The key difference: Novavax Inc is far larger — about 2.5× Standard Lithium Ltd's market cap, and Novavax Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| NVAX | SLI | |
|---|---|---|
Market Cap | $1.30B | $523.89M |
Sector | Health | Basic Materials |
52-Week High | $11.19 | $5.65 |
52-Week Low | $6.22 | $2.15 |
Enterprise Value | $800.50M | $383.09M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
